Russell Investments Group
CBIO

Russell Investments Group’s Crescent Biopharma CBIO Stock Holding History

Russell Investments Group’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-902
Closed -$338K – 3140
2020
Q4 		$338K Buy
902
+841
+1,379% +$295K ﹤0.01% 2578
2020
Q3 		$18K Sell
61
-163
-73% -$62.3K ﹤0.01% 3141
2020
Q2 		$83K Buy
+224
New +$63.4K ﹤0.01% 2921
2017
Q3 		– Sell
-314
Closed -$350K – 2968
2017
Q2 		$350K Buy
314
+199
+173% +$164K ﹤0.01% 2539
2017
Q1 		$63K Sell
115
-168
-59% -$103K ﹤0.01% 2874
2016
Q4 		$172K Buy
+283
New +$177K ﹤0.01% 2744

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return